ArticleStatistics in medicine2026
Dynamic Factor Analysis for Sparse and Irregular Longitudinal Data: An Application to Metabolite Measurements in a COVID-19 Study.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Factor analysis (FA) can be used to identify key biomarkers in biological processes by assuming that latent biological pathways (statistically, "latent factors") drive the activity of measurable biomarkers ("observed variables"). However, biological pathways often interact, meaning that the classical FA assumption of independence between factors is questionable. Motivated by sparsely and irregularly collected longitudinal measurements of metabolites in a COVID-19 study, we propose a dynamic factor analysis model that accounts for cross-correlations between pathways via a multi-output Gaussian processes (MOGP) prior on the factor trajectories. To mitigate against overfitting caused by sparsity of longitudinal measurements, we introduce a roughness penalty upon MOGP hyperparameters and allow for non-zero mean functions. We also propose a scalable stochastic expectation maximization (StEM) algorithm that, in simulations, is both 20 times faster and provides more accurate and stable MOGP hyperparameter estimates than a previously-proposed Monte Carlo Expectation Maximization algorithm. In the motivating COVID-19 study, our methodology identifies a kynurenine pathway that affects the clinical severity of patients with COVID-19 disease and uncovers the role of the biomarker taurine. Our R package DFA4SIL implements the proposed method.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.